Keely Langdon

Keely Langdon has a diverse work experience starting in 2011. Keely began their career at Health Advances as an Analyst before progressing to the role of Senior Analyst and eventually Consultant. In 2014, they had an externship as an Upstream Marketing Extern at HeartWare Inc. Langdon then joined HeartWare Inc as a New Business Development & Strategic Planning Analyst, Senior Analyst, and later as a Principal Analyst.

In 2016, Langdon moved to Medtronic where they served as a Strategic Marketing Manager and later as a Senior Product Manager, responsible for managing the Mechanical Circulatory Support franchise. Keely then joined Danaher Corporation as a GMDP (General Manager Development Program) and later pursued an MBA at Harvard Business School from 2017 to 2019.

After completing their MBA, Langdon returned to Danaher Corporation as a Danaher MBA Intern. Keely then joined Beckman Coulter Life Sciences as a Strategy Development Manager in 2019, where they contributed until their transition to Integrated DNA Technologies in 2020. At Integrated DNA Technologies, Langdon held various roles, including Director of Commercial Marketing, Director of Commercial Performance & Insights, Acquisition Transition Lead for Archer, and currently serves as the Director of Boulder Operations.

Keely Langdon attended Harvard Business School from 2017 to 2019, where they obtained a Master of Business Administration (MBA) degree. Prior to that, from 2007 to 2011, they earned a Bachelor of Arts degree in Health and Societies, with a concentration in Healthcare Markets and Finance, from the University of Pennsylvania. Additionally, Keely attended the Princeton Day School, although no specific dates or degrees were provided for this education institution.